Effect of myeloablative bone marrow transplantation on growth in children with sickle cell anaemia: results of the multicenter study of haematopoietic cell transplantation for sickle cell anaemia.
Effect of myeloablative bone marrow transplantation on growth in children with sickle cell anaemia: results of the multicenter study of haematopoietic cell transplantation for sickle cell anaemia.
复制标题
清髓性骨髓移植对镰状细胞性贫血儿童生长的影响:造血细胞移植治疗镰状细胞性贫血的多中心研究结果。
DOI:
10.1111/j.1365-2141.2006.06486.x
复制
发表时间:
2007
影响因子:
6.5
通讯作者:
Redding-Lall
中科院分区:
文献类型:
--
作者:
Eggleston,B;Patience,M;Edwards,S;Adamkiewicz,T;Buchanan,GR;Davies,SC;Dickerhoff,R;Donfield,S;Feig,SA;Giller,RH;Haight,A;Horan,J;Hsu,LL;Kamani,N;Lane,P;Levine,JE;Margolis,D;Moore,TB;Ohene-Frempong,K;Redding-Lall
Although haematopoietic cell transplantation (HCT) is curative for sickle cell anaemia (SCA), concerns about its short‐ and long‐term toxicities limit its application. A potential toxicity is an adverse effect on growth. To identify an HCT growth effect, serial height and weight measurements from 53 children and adolescents with SCA after receiving a transplant were compared to historical controls. Hierarchical Linear Models for longitudinal data were used for analysis. In general growth was not impaired by HCT for SCA in young children; however, diminished growth may occur if HCT is carried out near or during the adolescent growth spurt.